Chemical products and biological preparations
Title | Chemical products and biological preparations PDF eBook |
Author | United States. National Aeronautics and Space Administration |
Publisher | |
Pages | 18 |
Release | 1983 |
Genre | |
ISBN |
Chemical Products and Biological Preparations
Title | Chemical Products and Biological Preparations PDF eBook |
Author | United States. National Aeronautics and Space Administration |
Publisher | |
Pages | 12 |
Release | 1983* |
Genre | Crystal growth |
ISBN |
Merck's Index
Title | Merck's Index PDF eBook |
Author | |
Publisher | |
Pages | 496 |
Release | 1907 |
Genre | Biomolecules |
ISBN |
Rare Diseases and Orphan Products
Title | Rare Diseases and Orphan Products PDF eBook |
Author | Institute of Medicine |
Publisher | National Academies Press |
Pages | 442 |
Release | 2011-04-03 |
Genre | Medical |
ISBN | 0309158060 |
Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions is challenging. The Institute of Medicine (IOM) recommends implementing an integrated national strategy to promote rare diseases research and product development.
Clinical Pharmacology: Current Topics and Case Studies
Title | Clinical Pharmacology: Current Topics and Case Studies PDF eBook |
Author | Markus Müller |
Publisher | Springer Science & Business Media |
Pages | 438 |
Release | 2011-02-04 |
Genre | Medical |
ISBN | 3709101441 |
Today we witness an eventful time in which the powerful new forces of genomics, information technology and economics are rapidly changing the science and art of medicine. This will require more specialization than ever before. However, there is also an increasing demand for an integrated approach, which is provided by the discipline of Clinical Pharmacology (CP). CP pursues a scientific goal by studying drug action in patients and volunteers, a clinical goal by administering appropriate drug therapy and a regulatory goal by assessing the risk/benefit ratio of drug candidates in drug development and reimbursement. This introduction to current topics of CP covers traditional topics of clinical drug research and trial methodology but also provides insight in current topics like genomics, imaging technology and issues in drug reimbursement. A number of concrete case studies in clinical drug research and development help to give a better understanding of the general principles of CP.
Federal Regulation of Drugs, Biologicals, and Chemicals Used in Aquaculture Production
Title | Federal Regulation of Drugs, Biologicals, and Chemicals Used in Aquaculture Production PDF eBook |
Author | National Agricultural Library (U.S.) |
Publisher | |
Pages | 144 |
Release | 1992 |
Genre | Agricultural chemicals |
ISBN |
Chemical and Biological Terrorism
Title | Chemical and Biological Terrorism PDF eBook |
Author | Institute of Medicine |
Publisher | National Academies Press |
Pages | 303 |
Release | 1999-03-12 |
Genre | Technology & Engineering |
ISBN | 0309061954 |
The threat of domestic terrorism today looms larger than ever. Bombings at the World Trade Center and Oklahoma City's Federal Building, as well as nerve gas attacks in Japan, have made it tragically obvious that American civilians must be ready for terrorist attacks. What do we need to know to help emergency and medical personnel prepare for these attacks? Chemical and Biological Terrorism identifies the R&D efforts needed to implement recommendations in key areas: pre-incident intelligence, detection and identification of chemical and biological agents, protective clothing and equipment, early recognition that a population has been covertly exposed to a pathogen, mass casualty decontamination and triage, use of vaccines and pharmaceuticals, and the psychological effects of terror. Specific objectives for computer software development are also identified. The book addresses the differences between a biological and chemical attack, the distinct challenges to the military and civilian medical communities, and other broader issues. This book will be of critical interest to anyone involved in civilian preparedness for terrorist attack: planners, administrators, responders, medical professionals, public health and emergency personnel, and technology designers and engineers.